Overview

Robert J. Lefkowitz is an American physician-scientist and biochemist best known for transforming our understanding of G protein–coupled receptors (GPCRs). His laboratory combined clinical insight with biochemical and molecular approaches to reveal how cell-surface receptors recognize hormones, neurotransmitters and sensory stimuli, and how those receptors are regulated. Lefkowitz’s work was recognized with the 2012 Nobel Prize in Chemistry, shared with Brian Kobilka for studies on GPCR structure and function.

Research and key findings

Lefkowitz helped establish that GPCRs constitute a large family of membrane proteins that transmit extracellular signals into cells through interaction with G proteins. His group developed methods to label and purify receptors, identify receptor subtypes and follow receptor behavior inside cells. He elucidated mechanisms of receptor regulation, including phosphorylation-dependent desensitization and the role of arrestin proteins in turning receptor signaling on and off and in directing receptors to distinct cellular pathways.

Methods and collaborations

The research combined pharmacology, biochemistry, molecular cloning and later structural biology. While Lefkowitz mapped functional and regulatory features of GPCRs, collaborators and subsequent work used crystallography and cryo-electron microscopy to reveal three-dimensional receptor structures. The Nobel recognition honored the complementary nature of these approaches; see more on his profile at biography resources.

Impact and applications

GPCRs are among the most important targets in medicine: they mediate senses such as sight, smell and taste and regulate cardiovascular, nervous and endocrine systems. Drugs that activate or block GPCRs treat asthma, hypertension, psychiatric disorders and many other conditions. Lefkowitz’s insights into receptor activation, desensitization and internalization have influenced drug discovery, safety assessment and development of biased ligands that selectively trigger beneficial signaling pathways.

Career, positions and honors

Lefkowitz has held a long academic appointment at Duke University and serves as an investigator of the Howard Hughes Medical Institute. His career blends clinical training in internal medicine and cardiology with laboratory science; his standing in both medicine and basic research is reflected in numerous awards, culminating in the Nobel Prize with Brian Kobilka in 2012. Further institutional information is available at academic profile and at research summaries.

Legacy and notable facts

Beyond fundamental discoveries, Lefkowitz is noted as a mentor who trained many scientists who went on to contribute to pharmacology and cell biology. His work illustrates how mechanistic insights into receptor signaling can translate into broad medical applications. For additional reading and resources, including interviews and lectures, see selected materials.

  • Field: Pharmacology, biochemistry and medicine
  • Main focus: G protein–coupled receptors (GPCRs)
  • Notable award: Nobel Prize in Chemistry (2012)